Reda Zenagui

Dr. Reda Zenagui


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2021 in Genes
Verified
Journal Article
Open access
PDF file
RMRaul Juntas Morales
Raul Juntas Morales
APAurélien Perrin
Aurélien Perrin
GSGuilhem Solé
Guilhem Solé
DLDelphine Lacourt
Delphine Lacourt
HPHenri Pegeot
Henri Pegeot
MCMireille Cossée
Mireille Cossée
Diagnosis of myopathies is challenged by the high genetic heterogeneity and clinical overlap of the various etiologies. We previously reported a Next-Generation Sequencing strategy to identify genetic etiology in patients with undiagnosed Limb-Girdle Muscular Dystrophies, Congenital Myopathies, Congenital Muscular Dystrophies, Distal Myopathies, Myofibrillar Myopathies, and hyperCKemia or effort intolerance, using a large gene panel including genes classically associated with other entry diagnostic categories. In this study, we report the comprehensive clinical-biological strategy used to interpret NGS data in a cohort of 156 pediatric and adult patients, that included Copy Number Variants search, variants filtering and interpretation according to ACMG guidelines, segregation studies, deep phenotyping of patients and relatives, transcripts and protein studies, and multidisciplinary meetings. Genetic etiology was identified in 74 patients, a diagnostic yield (47.4%) similar to previous studies. We identified 18 patients (10%) with causative variants in different genes (ACTA1, RYR1, NEB, TTN, TRIP4, CACNA1S, FLNC, TNNT1, and PAPBN1) that resulted in milder and/or atypical phenotypes, with high intrafamilial variability in some cases. Mild phenotypes could mostly be explained by a less deleterious effect of variants on the protein. Detection of inter-individual variability and atypical phenotype-genotype associations is essential for precision medicine, patient care, and to progress in the understanding of the molecular mechanisms of myopathies.

11 March 2019 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
PDF file
RZReda Zenagui
Reda Zenagui
IBIzabel Bernicot
Izabel Bernicot
NRNoemie Ranisavljevic
Noemie Ranisavljevic
EHEmmanuelle Haquet
Emmanuelle Haquet
AFAlice Ferrieres-Hoa
Alice Ferrieres-Hoa
TATal Anahory
Tal Anahory

1 April 2022 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
RZReda Zenagui
Reda Zenagui
IBIzabel Bernicot
Izabel Bernicot
NRNoémie Ranisavljevic
Noémie Ranisavljevic
AFAlice Ferrieres-Hoa
Alice Ferrieres-Hoa
JPJacques Puechberty
Jacques Puechberty
TATal Anahory
Tal Anahory

4 December 2020 in Research Square
Verified
Preprint
Open access
PDF file
RZReda Zenagui
Reda Zenagui
IBIzabel Bernicot
Izabel Bernicot
CCCendrine Ciabrini
Cendrine Ciabrini
AHAlice Ferrieres Hoa
Alice Ferrieres Hoa
CCChristel Castelli
Christel Castelli
TATal Anahory
Tal Anahory
Robertsonian translocation (RT) carriers are phenotypically normal, but they are known to be at increased risk of repeated miscarriages compared with the general population estimated at about 15% of pregnancies, and also resulting in the birth of a child with a mental retardation or congenital anomalies. Preimplantation Genetic Testing (PGT) is therefore a solution for RT carriers. An appropriate probe strategy allows to differentiate balanced embryos, unbalanced embryos, and mosaic embryos. We performed the first comparative analysis between two or three probes FISH strategies to analyze if a probe strategy choice for PGT-SR studies of Robertsonian translocations (RT) influences the fate of embryos? Our investigations present 13 years of experience of PGT for Robertsonian translocation carriers to improve the accuracy of abnormality detections. A deeper analysis of 283 PGT-SR attempts by comparing two strategies of probes highlighted the irrelevance of using a third probe for FISH diagnosis and above all a significant difference of mosaic embryo rates between probe strategies. These findings could be used as new recommendations of Robertsonian translocation management in many laboratories to improve their practices. It could be readily run, less expensive, reliable and accurate. Furthermore, the propounded strategy of mosaic embryo transfer should be considered after a detailed genetic counseling.